dendritic-cells

Documents about dendritic-cells

• Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer#125951ClinicalTrials.gov
• The Double-Stranded RNA Bluetongue Virus Induces Type I Interferon in Plasmacytoid Dendritic Cells via a MYD88-Dependent TLR7/8-Independent Signaling Pathway#196800HAL (France)
• Identification of allo- or orthosteric VHH/single-domain antibodies that enhance or block pathogen binding to Siglec-1 on dendritic cells#296762Europe PMC
• HSV-1 alters lipid metabolism and induces lipid droplet accumulation in functionally impaired mouse dendritic cells#465749Repositorio Universidad del Desarrollo
• A Vaccine Study for High Risk Cancers#895406ClinicalTrials.gov
• Identification of human DP8α regulatory T cell sub-populations reactive to health-associated anti-inflammatory gut commensals#347889HAL (France)
• The Treatment of Patients With Type 1 Diabetes Mellitus With Autologous Tolerogenic Dendritic Cells#180321ClinicalTrials.gov
• A Phase I Study of Immunotherapy With GSC -Loaded Dendritic Cells in Patients With Recurrent Glioblastoma#467634ClinicalTrials.gov
• Personalized Vaccine for Cancer Immunotherapy#836574ClinicalTrials.gov
• Characteristics of Dendritic Cells Before and After Gastric Banding#905443ClinicalTrials.gov
• Clinical Trial of SBRT and Systemic Pembrolizumab With or Without Avelumab/Ipilimumab+ Dendritic Cells in Solid Tumors#910347ClinicalTrials.gov
• Vaccination by Leukemic Apoptotic Corpse Autologous Pulsed Dendritic Cells for Acute Myelogenous Leukemia (AML) Patients in First or Second Complete Remission (CR)(CD laM)#125906ClinicalTrials.gov
• Dendritic cells activated with products released by schistosome larvae drive Th2-type immune responses, which can be inhibited by manipulation of CD40 costimulation#386293White Rose Research Online
• Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden#208464ClinicalTrials.gov
• Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative breast cancer.#265381NCBI PubMed Central
• CCL2: A double-edged sword in neuroblastoma, with a critical role in MYCN-amplified tumors#392018HAL (France)
• Utilisation de la thérapie cellulaire à l'aide de cellules dendritiques tolérogènes autologues en transplantation et dans les pathologies inflammatoires#482559HAL (France)
• Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma#683119ClinicalTrials.gov
• Genetic Susceptibility to Ankylosing Spondylitis (AS) by Functional Genomics Approach#800911ClinicalTrials.gov
• mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma#832023ClinicalTrials.gov
• Phase I-II Vaccination of Autologous Dendritic Cells Transduced With Adenoviral Vector Encoding NS3 in Hepatitis C Encoding NS3 in Hepatitis C#245578ClinicalTrials.gov
• Overexpression of Synaptopodin increases the number of spine apparatuses and active synapses of dentate granule cells#273287Europe PMC
• MiHA-loaded PD-L-silenced DC Vaccination After Allogeneic SCT#979133ClinicalTrials.gov
• CD8 Reactivity to Microorganisms in Blood and Breast Milk#842468ClinicalTrials.gov
• Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma#848009ClinicalTrials.gov
• Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias#184921ClinicalTrials.gov
• Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma#343691ClinicalTrials.gov
• A Pilot Study Assessing Intra-Metastasis Administration of Autologous KLH-pulsed Dendritic Cells With Tumoral Radiation Therapy in Patients With Metastatic Pancreatic Carcinoma#812744ClinicalTrials.gov
• Investigating the immunomodulatory properties of Nippostrongylus brasiliensis; a potential model for Necator americanus#990192University of Nottingham Repository
• A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA#417546ClinicalTrials.gov
• Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas#1009561ClinicalTrials.gov
• Dataset for "<b>Transient NMDAR-CaMKII signalling resolves competition among dendritic trees to establish Purkinje cell architecture</b>"#391584Figshare
• A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma#881062ClinicalTrials.gov
• Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.#398191ClinicalTrials.gov
• Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC#435769ClinicalTrials.gov
• Control of antigen cross-presentation through selective engagement of the mannose receptor#632061University of Nottingham Repository
• Safety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SC#807755ClinicalTrials.gov
• CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial#226247ClinicalTrials.gov
• Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma#467628ClinicalTrials.gov
• Pembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC)#835479ClinicalTrials.gov
• DCVAC/OvCa After Standard-of-care Chemotherapy in Women With Relapse of Platinum-sensitive Epithelial Ovarian Cancer#891291ClinicalTrials.gov
• Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.#343710ClinicalTrials.gov
• Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer#279514ClinicalTrials.gov
• Caractérisation du rôle de la voie IRE1/XBP1 de la réponse UPR dans le processus de maturation immunogénique et les fonctions des cDC1 spléniques lors de l'infection à Toxoplasma gondii#643299HAL (France)
• The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapy#996252eScholarship
• Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial#467610ClinicalTrials.gov
• Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome#1030175ClinicalTrials.gov
• Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer#980806ClinicalTrials.gov